EFFECT OF SUPER INDUCTIVE SYSTEM THERAPY COMBINED WITH MCIMT ON SPASTIC HAND IN STROKE PATIENTS– A SINGLE BLINDED, RANDOMIZED CONTROLLED TRIAL.

This study aims to investigate the effect of**Super Inductive System (SIS) therapy combined with modified Constraint-Induced Movement Therapy (mCIMT)**on hand spasticity and upper limb function in individuals with stroke. Post stroke spasticity is a common and disabling motor disorder that limits functional independence, reduces quality of life, and leads to secondary complications such as contractures, pain, and pressure sores. Although conventional physiotherapy, pharmacological management, and invasive procedures are available, they often provide only short term benefits or have limitations related to cost, accessibility, and adverse effects.

mCIMT is an evidence based intervention that promotes use of the affected limb through intensive task specific training and restraint of the unaffected limb, thereby enhancing neuroplasticity and functional recovery. However, its direct effect on spasticity is limited, especially in patients with marked hypertonia. SIS therapy is a recent, non invasive modality that uses high intensity electromagnetic stimulation to induce controlled muscle contractions, improve circulation, modulate neuromuscular activity, and reduce muscle tone. The combined application of SIS and mCIMT is expected to produce complementary effects by reducing spasticity physiologically while simultaneously promoting motor relearning and functional use of the hand.

This single-blinded randomized controlled trial will be conducted on 16 stroke patients recruited from a tertiary care hospital and allocated into two groups: mCIMT alone and SIS with mCIMT. The intervention will be administered over two weeks. Outcomes will be measured using the Modified Ashworth Scale, Fugl-Meyer Assessment for Upper Extremity,  Nine Hole Peg Test, goniometry, and the DASH questionnaire.

The study intends to establish an effective, non invasive, multimodal rehabilitation approach for improving hand function, dexterity, and quality of life in stroke survivors.